GTPBP5, also known as GTP-binding protein 5, is a member of the GTPase family of proteins, which play crucial roles in various cellular processes due to their ability to hydrolyze guanosine triphosphate (GTP) to guanosine diphosphate (GDP). GTPases act as molecular switches within the cell, cycling between an active GTP-bound state and an inactive GDP-bound state, thereby regulating a wide array of biological functions including signal transduction, protein synthesis, cell division, and vesicle trafficking.
GTPBP5 is characterized by its conserved GTPase domain, which is responsible for binding and hydrolyzing GTP. The specific function of GTPBP5 within the cell is less clear compared to some of its more well-studied relatives, but it is believed to be involved in the regulation of ribosome function and the accuracy of protein synthesis. This is in line with other GTPases that are known to interact with ribosomal subunits and participate in translation regulation.The expression of GTPBP5 is ubiquitous, indicating that it may have fundamental roles in general cellular metabolism. However, the precise mechanisms by which GTPBP5 influences ribosomal activity and translation fidelity are not completely understood. It is thought that GTPBP5 may exert its effects by interacting with other ribosomal proteins or with the translation machinery directly to ensure proper assembly of the ribosome or the correct elongation of the polypeptide chain during protein synthesis.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin elevates cAMP levels, which may affect GTPase-mediated signaling pathways, potentially impacting GTPBP5. | ||||||
AICAR | 2627-69-2 | sc-200659 sc-200659A sc-200659B | 50 mg 250 mg 1 g | $65.00 $280.00 $400.00 | 48 | |
AICAR activates AMPK and may influence GTPase activity, thereby potentially affecting GTPBP5. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
This ROCK inhibitor can modulate GTPase signaling pathways, potentially influencing GTPBP5. | ||||||
Lovastatin | 75330-75-5 | sc-200850 sc-200850A sc-200850B | 5 mg 25 mg 100 mg | $29.00 $90.00 $339.00 | 12 | |
Lovastatin, by inhibiting HMG-CoA reductase, can affect prenylation of GTPases, potentially impacting GTPBP5. | ||||||
GGTI 298 | 1217457-86-7 | sc-361184 sc-361184A | 1 mg 5 mg | $193.00 $838.00 | 2 | |
GGTI-298 inhibits geranylgeranyltransferase, affecting GTPase activity, which might influence GTPBP5. | ||||||
Palbociclib | 571190-30-2 | sc-507366 | 50 mg | $321.00 | ||
Palbociclib, a CDK4/6 inhibitor, might influence GTPase-mediated signaling pathways, indirectly affecting GTPBP5. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126, a MEK inhibitor, can impact MAPK/ERK signaling, potentially influencing GTPBP5 activity. | ||||||